End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29,050 KRW | +0.52% | -0.17% | +4.68% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2024 * | 213B 154M | Sales 2025 * | 233B 168M | Capitalization | 171B 123M |
---|---|---|---|---|---|
Net income 2024 * | 30B 21.66M | Net income 2025 * | 33B 23.83M | EV / Sales 2024 * | 0.15 x |
Net cash position 2024 * | 138B 99.64M | Net cash position 2025 * | 163B 118M | EV / Sales 2025 * | 0.03 x |
P/E ratio 2024 * |
5.66
x | P/E ratio 2025 * |
5.25
x | Employees | 553 |
Yield 2024 * |
2.41% | Yield 2025 * |
2.5% | Free-Float | 59.32% |
1 day | +0.52% | ||
1 week | -0.17% | ||
1 month | +2.11% | ||
3 months | +0.17% | ||
6 months | +5.06% | ||
Current year | +4.68% |
Managers | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Seong-Soo Yoon
AUD | Comptroller/Controller/Auditor | 46 | 17-03-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon-Woo Lee
CEO | Chief Executive Officer | 80 | 69-06-30 |
Seung-Young Lee
BRD | Director/Board Member | 51 | 02-02-28 |
Dong-Il Lee
BRD | Director/Board Member | 71 | 02-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 29,050 | +0.52% | 4,239 |
24-05-30 | 28,900 | -.--% | 9,008 |
24-05-29 | 28,900 | -0.69% | 3,868 |
24-05-28 | 29,100 | -.--% | 3,611 |
24-05-27 | 29,100 | -.--% | 6,702 |
End-of-day quote Korea S.E., May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.68% | 124M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A023910 Stock